BRIEF published on 05/28/2024 at 13:35, 1 year 6 months ago Alta Global Group améliore l'expérience des fans de MMA grâce à un partenariat City Kickboxing Partenariat Sports De Combat Groupe Mondial Alta Formation MMA Kickboxing En Ville
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago Rentschler Biopharma nomme Patrick Meyer au poste de responsable mondial des ventes et de la gestion des alliances BD Rentschler Biopharma Produits Biopharmaceutiques Développement Des Affaires Patrick Meyer
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Develop Peptide-Conjugated Antisense Therapeutics Collaboration Secarna Pharmaceuticals Orbit Discovery Antisense Therapeutics Peptide-Conjugated
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago Secarna Pharmaceuticals et Orbit Discovery concluent une collaboration pour développer des produits thérapeutiques antisens conjugués à des peptides Collaboration Secarna Pharmaceutique Découverte De L'orbite Thérapeutique Antisens Conjugué Aux Peptides
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago HomeToGo Releases Results of Its Annual General Meeting 2024 Annual General Meeting Shareholders Frankfurt Stock Exchange 2024 HomeToGo
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago HomeToGo publie les résultats de son assemblée générale annuelle 2024 Actionnaires 2024 Bourse De Francfort Assemblée Générale Annuelle AccueilÀGo
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago CureVac Announces Dosing of First Participant in Phase 2 Influenza Study GSK MRNA Technology Phase 2 Study CureVac Influenza Vaccine
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago CureVac annonce le dosage du premier participant à l'étude de phase 2 sur la grippe GSK Technologie ARNm Étude De Phase 2 CureVac Vaccin Contre La Grippe
BRIEF published on 05/28/2024 at 13:05, 1 year 6 months ago SRQ Resources Announces New Nickel-Copper Intercepts at Lac Brulé Drilling Quebec Nickel Copper Discovery
Published on 12/14/2025 at 23:00, 4 hours 27 minutes ago Fortescue to Acquire Alta Copper for C$1.40 per Share
Published on 12/13/2025 at 02:00, 2 days 1 hour ago Battery X Metals Announces Confidential Submission of Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 12/13/2025 at 00:13, 2 days 3 hours ago Prospect Ridge Announces Non-Brokered Private Placement
Published on 12/12/2025 at 23:05, 2 days 4 hours ago ReelTime's RLTR Stock Surges Past AI Giants Following LG Smart TV Debut of Reel Intelligence
Published on 12/14/2025 at 14:10, 13 hours 16 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 12/13/2025 at 19:57, 1 day 7 hours ago The Payments Group Holding identifies business activity fields and investment opportunities in AI company building and the biotech sector
Published on 12/13/2025 at 17:00, 1 day 10 hours ago Tapping into "Urban Oilfield": Unlocking the Value of Waste Plastic Film
Published on 12/13/2025 at 11:20, 1 day 16 hours ago Official streaming platform for the Games of the Future Abu Dhabi 2025 powered by ADNOC launches ahead of opening competition
Published on 12/13/2025 at 04:15, 1 day 23 hours ago M7 World Championship unveils first Opening Ceremony, tournament draw, and M7 Pass—elevates Indonesia on global stage
Published on 12/12/2025 at 18:00, 2 days 9 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 18:00, 2 days 9 hours ago Déclaration des transactions sur actions propres réalisées du 24 novembre au 28 novembre 2025
